Treats acute lymphoblastic leukemia. ANDA 201529, held by Eugia Pharma Specialities. Methotrexate Sodium.
As of Nov 20, 2026, ANDA 201529 (Methotrexate Sodium Preservative Free), held by Eugia Pharma Specialities, was first approved by FDA on Mar 29, 2012, with 4 approved supplements and 0 published complete response letters.
Methotrexate Injection is a folate analog metabolic inhibitor indicated for: The following neoplastic diseases for the: โฆ Treatment of adult and pediatric patients with acute lymphoblastic leukemia as part of a combination chemotherapy regimen. โฆ Prophylaxis and treatment of adult and pediatric patients with meningeal leukemia. โฆ Treatment of adult and pediatric patients with non-Hodgkin lymphoma. โฆ Treatment of adult and pediatric patients with osteosarcoma as part of a combination chemotherapy regimen. โฆ Treatment of adults with breast cancer as part of a combination chemotherapy regimen. โฆ Treatment of adults with squamous cell carcinoma of the head and neck as a single agent.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 29, 2012 | Original application | Approved | None posted |
| Methotrexate Sodium Preservative FreeEQ 50MG BASE/2ML (EQ 25MG BASE/ML) ยท injectable;injection | Methotrexate Sodium | Rx |
| Methotrexate Sodium Preservative FreeEQ 100MG BASE/4ML (EQ 25MG BASE/ML) ยท injectable;injection | Methotrexate Sodium | Rx |
| Methotrexate Sodium Preservative FreeEQ 200MG BASE/8ML (EQ 25MG BASE/ML) ยท injectable;injection | Methotrexate Sodium | Rx |
| Methotrexate Sodium Preservative FreeEQ 250MG BASE/10ML (EQ 25MG BASE/ML) ยท injectable;injection | Methotrexate Sodium | Rx |
| Jul 19, 2021 | Supplement 7Labeling ยท Standard review | Approved | None posted |
| Jul 19, 2021 | Supplement 10Labeling ยท Standard review | Approved | None posted |
| Oct 5, 2015 | Supplement 3Labeling ยท Standard review | Approved | None posted |
| Oct 5, 2015 | Supplement 4Labeling ยท Standard review | Approved | None posted |
| Mar 29, 2012 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. โWhat FDA's review saysโ is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters